These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35419626)

  • 1. A case of plasma cell neoplasm-associated chronic neutrophilic leukemia with ASXL1 and JAK2V617F mutations.
    Lauw MIS; Hakim N; Arora S; Prakash S; Xie Y
    Ann Hematol; 2022 Aug; 101(8):1879-1881. PubMed ID: 35419626
    [No Abstract]   [Full Text] [Related]  

  • 2. CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia.
    Qian Y; Chen Y; Li X
    Ann Hematol; 2021 Jun; 100(6):1459-1461. PubMed ID: 33822276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF3R-, ASXL1-, and SETBP1-mutated chronic neutrophilic leukemia with monoclonal gammopathy of undetermined significance in a patient who developed severe ascites due to sinusoidal neutrophilic infiltration.
    Harada N; Mukai D; Izuta Y; Shibano I; Kizawa Y; Shiragami H; Ohnishi N; Hosaka N; Mugitani A
    Pathol Int; 2024 Feb; 74(2):93-95. PubMed ID: 38050833
    [No Abstract]   [Full Text] [Related]  

  • 4. ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia.
    Elliott MA; Pardanani A; Hanson CA; Lasho TL; Finke CM; Belachew AA; Tefferi A
    Am J Hematol; 2015 Jul; 90(7):653-6. PubMed ID: 25850813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF3R T618I, ASXL1 G942 fs and STAT5B N642H trimutation co-contribute to a rare chronic neutrophilic leukaemia manifested by rapidly progressive leucocytosis, severe infections, persistent fever and deep venous thrombosis.
    Luo Q; Shen J; Yang Y; Tang H; Shi M; Liu J; Liu Z; Shi X; Yi Y
    Br J Haematol; 2018 Mar; 180(6):892-894. PubMed ID: 27984641
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia.
    Yin B; Chen X; Gao F; Li J; Wang HW
    Hematology; 2019 Dec; 24(1):538-543. PubMed ID: 31315541
    [No Abstract]   [Full Text] [Related]  

  • 7. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
    Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CSF3R, ASXL1,SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia].
    Cui Y; Li B; Jiang Q; Xu Z; Qin T; Zhang P; Zhang Y; Xiao Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1069-73. PubMed ID: 25543699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent
    Gunawan AS; McLornan DP; Wilkins B; Waghorn K; Hoade Y; Cross NCP; Harrison CN
    Haematologica; 2017 Jun; 102(6):e238-e240. PubMed ID: 28302714
    [No Abstract]   [Full Text] [Related]  

  • 10. Genomics of chronic neutrophilic leukemia.
    Maxson JE; Tyner JW
    Blood; 2017 Feb; 129(6):715-722. PubMed ID: 28028025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe congenital neutropenia and chronic neutrophilic leukemia: an intriguing molecular connection unveiled by oncogenic mutations in CSF3R.
    Touw IP; Beekman R
    Haematologica; 2013 Oct; 98(10):1490-2. PubMed ID: 24091926
    [No Abstract]   [Full Text] [Related]  

  • 12. Never judge a book by its cover: these neutrophils are not reactive!
    Rieu JB; Vergez F
    Blood; 2019 Aug; 134(7):656. PubMed ID: 31416815
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.
    Stahl M; Xu ML; Steensma DP; Rampal R; Much M; Zeidan AM
    Ann Hematol; 2016 Jun; 95(7):1197-200. PubMed ID: 27068405
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic neutrophilic leukemia in a child with a CSF3R T618I germ line mutation.
    Druhan LJ; McMahon DP; Steuerwald N; Price AE; Lance A; Gerber JM; Avalos BR
    Blood; 2016 Oct; 128(16):2097-2099. PubMed ID: 27581359
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetically informed therapy in leukemia.
    Radich J
    N Engl J Med; 2013 May; 368(19):1838-9. PubMed ID: 23656651
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic neutrophilic leukemia with CSF3R mutation and concurrent multiple myeloma: one case report].
    He M; Zhao XC; Bai H
    Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1052. PubMed ID: 32023742
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel colony stimulating factor 3 receptor activating mutation identified in a patient with chronic neutrophilic leukemia.
    Maniaci BN; Chung J; Sanz-Altamira P; DeAngelo DJ; Maxson JE
    Haematologica; 2023 Jul; 108(7):1945-1950. PubMed ID: 36579444
    [No Abstract]   [Full Text] [Related]  

  • 18. CSF3R is mutated in chronic neutrophilic leukemia and atypical CML.
    Cancer Discov; 2013 Jul; 3(7):OF23. PubMed ID: 23847367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia Cell Lines: In Vitro Models for the Study of Chronic Neutrophilic Leukemia.
    Drexler HG; Nagel S; Quentmeier H
    Curr Oncol; 2021 May; 28(3):1790-1794. PubMed ID: 34068566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia.
    Duployez N; Willekens C; Plo I; Marceau-Renaut A; de Botton S; Fenwarth L; Boyer T; Huet G; Nibourel O; Rose C; Nelken B; Quesnel B; Preudhomme C
    Blood; 2019 Dec; 134(26):2414-2416. PubMed ID: 31697825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.